Jacobs Levy Equity Management’s RXO RXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-118,057
Closed -$1.49M 1050
2025
Q4
$1.49M Buy
+118,057
New +$1.74M 0.01% 626
2025
Q1
Sell
-391,434
Closed -$9.33M 1179
2024
Q4
$9.33M Sell
391,434
-144,670
-27% -$4.04M 0.03% 316
2024
Q3
$15M Sell
536,104
-635,561
-54% -$17.9M 0.06% 271
2024
Q2
$30.6M Buy
1,171,665
+78,286
+7% +$1.63M 0.13% 164
2024
Q1
$23.9M Sell
1,093,379
-5,270
-0.5% -$113K 0.11% 194
2023
Q4
$25.6M Buy
1,098,649
+229,828
+26% +$4.62M 0.13% 176
2023
Q3
$17.1M Buy
868,821
+646,540
+291% +$12.7M 0.1% 198
2023
Q2
$5.04M Buy
+222,281
New +$4.48M 0.03% 387

Other funds holding RXO

Jacobs Levy Equity Management's RXO Position: Q1 2026 in Review

Jacobs Levy Equity Management sold out of RXO (RXO) in Q1 2026, closing a stake of 118,057 shares — an estimated $1.49M sold.

Jacobs Levy Equity Management first reported a position in RXO in Q2 2023 and held it in 8 quarters. The position peaked at $30.6M in Q2 2024. 274 funds tracked by Wall St. Rank hold RXO as of Q1 2026.

  • Jacobs Levy Equity Management reported no remaining RXO position as of Q1 2026 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 118,057 RXO shares in Q1 2026, an estimated $1.49M.
  • Jacobs Levy Equity Management first reported a position in RXO in Q2 2023 and held it in 8 quarters.
  • Jacobs Levy Equity Management's RXO position peaked at $30.6M in Q2 2024.
  • 274 funds tracked by Wall St. Rank held RXO as of Q1 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2026, filed 15 May 2026.